$SCLN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SCICLONE PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in SCICLONE PHARMACEUTICALS INC. Get notifications about new insider transactions in SCICLONE PHARMACEUTICALS INC for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President, CEO, Dir ... | Option Exercise | M | 0.00 | 20,000 | 0 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President, CEO, Dir ... | Option Exercise | D | 9.65 | 129,157 | 1,246,365 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President, CEO, Dir ... | Option Exercise | D | 9.65 | 10,843 | 104,635 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President, CEO, Dir ... | Option Exercise | M | 0.00 | 15,000 | 0 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President, CEO, Dir ... | Option Exercise | D | 9.12 | 128,757 | 1,174,264 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President, CEO, Dir ... | Option Exercise | D | 9.12 | 11,243 | 102,536 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President, CEO, Dir ... | Option Exercise | M | 0.00 | 50,000 | 0 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President, CEO, Dir ... | Option Exercise | D | 8.83 | 97,275 | 858,938 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President, CEO, Dir ... | Option Exercise | M | 0.00 | 10,000 | 0 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President, CEO, Dir ... | Option Exercise | D | 8.83 | 42,725 | 377,262 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President, CEO, Dir ... | Option Exercise | D | 4.52 | 200,000 | 904,000 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President, CEO, Dir ... | Option Exercise | D | 4.53 | 200,000 | 906,000 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President, CEO, Dir ... | Option Exercise | D | 6.22 | 200,000 | 1,244,000 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President, CEO, Dir ... | Option Exercise | D | 5.13 | 142,610 | 731,589 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President, CEO, Dir ... | Sell | D | 11.18 | 387,299 | 4,330,003 | 0 | 387.3 K to 0 (-100.00 %) |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President, CEO, Dir ... | Grant | A | 0.00 | 150,000 | 0 | 387,299 | 237.3 K to 387.3 K (+63.21 %) |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President, CEO, Dir ... | Buy | M | 0.00 | 95,000 | 0 | 237,299 | 142.3 K to 237.3 K (+66.76 %) |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | SAXE JON S | Director | Option Exercise | D | 10.90 | 30,000 | 327,000 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | SAXE JON S | Director | Option Exercise | D | 9.15 | 30,000 | 274,500 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | SAXE JON S | Director | Option Exercise | D | 5.10 | 30,000 | 153,000 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | SAXE JON S | Director | Option Exercise | D | 5.13 | 30,000 | 153,900 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | SAXE JON S | Director | Option Exercise | D | 6.78 | 30,000 | 203,400 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | SAXE JON S | Director | Option Exercise | D | 6.04 | 30,000 | 181,200 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | SAXE JON S | Director | Option Exercise | D | 3.01 | 30,000 | 90,300 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | SAXE JON S | Director | Option Exercise | D | 2.23 | 30,000 | 66,900 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | SAXE JON S | Director | Option Exercise | D | 1.75 | 30,000 | 52,500 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | SAXE JON S | Director | Sell | D | 11.18 | 135,000 | 1,509,300 | 0 | 135 K to 0 (-100.00 %) |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Low Raymond Anthony | VP, Finance & Contr ... | Option Exercise | D | 9.65 | 24,426 | 235,711 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Low Raymond Anthony | VP, Finance & Contr ... | Option Exercise | D | 9.65 | 10,574 | 102,039 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Low Raymond Anthony | VP, Finance & Contr ... | Option Exercise | M | 0.00 | 5,000 | 0 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Low Raymond Anthony | VP, Finance & Contr ... | Option Exercise | M | 0.00 | 3,750 | 0 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Low Raymond Anthony | VP, Finance & Contr ... | Option Exercise | D | 9.12 | 19,077 | 173,982 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Low Raymond Anthony | VP, Finance & Contr ... | Option Exercise | D | 9.12 | 15,923 | 145,218 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Low Raymond Anthony | VP, Finance & Contr ... | Option Exercise | D | 8.83 | 3,988 | 35,214 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Low Raymond Anthony | VP, Finance & Contr ... | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Low Raymond Anthony | VP, Finance & Contr ... | Option Exercise | D | 8.83 | 31,012 | 273,836 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Low Raymond Anthony | VP, Finance & Contr ... | Option Exercise | D | 4.75 | 50,000 | 237,500 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Low Raymond Anthony | VP, Finance & Contr ... | Sell | D | 11.18 | 37,748 | 422,023 | 0 | 37.7 K to 0 (-100.00 %) |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Low Raymond Anthony | VP, Finance & Contr ... | Buy | M | 0.00 | 11,250 | 0 | 37,748 | 26.5 K to 37.7 K (+42.46 %) |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Option Exercise | D | 9.65 | 84,000 | 810,600 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Option Exercise | M | 0.00 | 12,000 | 0 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Option Exercise | M | 0.00 | 9,000 | 0 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Option Exercise | D | 9.12 | 84,000 | 766,080 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Option Exercise | M | 0.00 | 6,000 | 0 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Option Exercise | D | 8.83 | 84,000 | 741,720 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Option Exercise | D | 4.52 | 90,000 | 406,800 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Sell | D | 11.18 | 127,000 | 1,419,860 | 0 | 127 K to 0 (-100.00 %) |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Grant | A | 0.00 | 75,000 | 0 | 127,000 | 52 K to 127 K (+144.23 %) |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Buy | M | 0.00 | 52,000 | 0 | 52,000 | 0 to 52 K |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Li Simon | Director | Option Exercise | D | 10.90 | 30,000 | 327,000 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Li Simon | Director | Option Exercise | D | 9.15 | 30,000 | 274,500 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Li Simon | Director | Option Exercise | D | 5.10 | 30,000 | 153,000 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Li Simon | Director | Option Exercise | D | 5.13 | 12,500 | 64,125 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Li Simon | Director | Option Exercise | D | 4.85 | 50,000 | 242,500 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | CHANG NANCY T | Director | Option Exercise | D | 10.90 | 30,000 | 327,000 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | CHANG NANCY T | Director | Option Exercise | D | 9.15 | 30,000 | 274,500 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | CHANG NANCY T | Director | Sell | D | 11.18 | 70,000 | 782,600 | 0 | 70 K to 0 (-100.00 %) |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | D | 10.90 | 30,000 | 327,000 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | D | 9.15 | 30,000 | 274,500 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | D | 5.10 | 30,000 | 153,000 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | D | 5.13 | 30,000 | 153,900 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | D | 6.78 | 30,000 | 203,400 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | D | 6.04 | 30,000 | 181,200 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | D | 3.01 | 30,000 | 90,300 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | D | 2.23 | 5,000 | 11,150 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | D | 1.24 | 50,000 | 62,000 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Chern Carey | General Counsel | Option Exercise | M | 0.00 | 30,000 | 0 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Chern Carey | General Counsel | Option Exercise | D | 10.35 | 41,356 | 428,035 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Chern Carey | General Counsel | Option Exercise | D | 10.35 | 38,644 | 399,965 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Chern Carey | General Counsel | Buy | D | 11.18 | 20,708 | 231,515 | 0 | -20,708 to 0 (-100.00 %) |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Chern Carey | General Counsel | Payment of Exercise | F | 11.18 | 11,274 | 126,043 | 20,708 | 32 K to 20.7 K (-35.25 %) |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Chern Carey | General Counsel | Buy | M | 0.00 | 30,000 | 0 | 31,982 | 2 K to 32 K (+1,513.62 %) |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Option Exercise | D | 9.65 | 21,000 | 202,650 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Option Exercise | M | 0.00 | 3,000 | 0 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Option Exercise | M | 0.00 | 3,000 | 0 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Option Exercise | D | 9.12 | 28,000 | 255,360 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Option Exercise | M | 0.00 | 2,000 | 0 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Option Exercise | D | 8.83 | 18,667 | 164,830 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Option Exercise | D | 4.52 | 16,667 | 75,335 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Option Exercise | D | 4.53 | 2,500 | 11,325 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Sell | D | 11.18 | 8,000 | 89,440 | 0 | 8 K to 0 (-100.00 %) |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Buy | M | 0.00 | 8,000 | 0 | 8,000 | 0 to 8 K |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Hawkins Richard J | Director | Option Exercise | D | 10.90 | 30,000 | 327,000 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Hawkins Richard J | Director | Option Exercise | D | 9.15 | 30,000 | 274,500 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Hawkins Richard J | Director | Option Exercise | D | 5.10 | 30,000 | 153,000 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Hawkins Richard J | Director | Option Exercise | D | 5.13 | 30,000 | 153,900 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Hawkins Richard J | Director | Option Exercise | D | 6.78 | 30,000 | 203,400 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Hawkins Richard J | Director | Option Exercise | D | 6.04 | 30,000 | 181,200 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Hawkins Richard J | Director | Sell | D | 11.18 | 24,363 | 272,378 | 0 | 24.4 K to 0 (-100.00 %) |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Option Exercise | D | 9.65 | 73,349 | 707,818 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Option Exercise | D | 9.65 | 10,651 | 102,782 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Option Exercise | M | 0.00 | 12,000 | 0 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Option Exercise | M | 0.00 | 9,000 | 0 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Option Exercise | D | 9.12 | 72,869 | 664,565 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Option Exercise | D | 9.12 | 11,131 | 101,515 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Option Exercise | D | 8.83 | 44,775 | 395,363 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Option Exercise | M | 0.00 | 6,000 | 0 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Option Exercise | D | 8.83 | 39,225 | 346,357 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Option Exercise | D | 4.52 | 24,792 | 112,060 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Option Exercise | D | 5.97 | 9,375 | 55,969 | 0 | |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Sell | D | 11.18 | 144,158 | 1,611,686 | 0 | 144.2 K to 0 (-100.00 %) |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Grant | A | 0.00 | 75,000 | 0 | 144,158 | 69.2 K to 144.2 K (+108.45 %) |
| Oct 16 2017 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Buy | M | 0.00 | 52,000 | 0 | 69,158 | 17.2 K to 69.2 K (+303.07 %) |
| Aug 16 2017 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Option Exercise | M | 0.00 | 30,000 | 0 | 127,000 | |
| Aug 16 2017 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Payment of Exercise | F | 11.05 | 14,714 | 162,590 | 17,158 | 31.9 K to 17.2 K (-46.17 %) |
| Aug 16 2017 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Buy | M | 0.00 | 30,000 | 0 | 31,872 | 1.9 K to 31.9 K (+1,602.56 %) |
| Aug 16 2017 | SCLN | SCICLONE PHARMACEU ... | Low Raymond Anthony | VP, Finance & Contr ... | Option Exercise | M | 0.00 | 10,000 | 0 | 11,250 | |
| Aug 16 2017 | SCLN | SCICLONE PHARMACEU ... | Low Raymond Anthony | VP, Finance & Contr ... | Buy | M | 0.00 | 10,000 | 0 | 25,536 | 15.5 K to 25.5 K (+64.37 %) |
| Aug 16 2017 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Option Exercise | M | 0.00 | 30,000 | 0 | 127,000 | |
| Aug 16 2017 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Sell | S | 11.00 | 30,000 | 330,000 | 0 | 30 K to 0 (-100.00 %) |
| Aug 16 2017 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Buy | M | 0.00 | 30,000 | 0 | 30,000 | 0 to 30 K |
| Aug 16 2017 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Option Exercise | M | 0.00 | 10,000 | 0 | 8,000 | |
| Aug 16 2017 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Sell | S | 11.00 | 10,000 | 110,000 | 0 | 10 K to 0 (-100.00 %) |
| Aug 16 2017 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Buy | M | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| Aug 16 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 0.00 | 40,000 | 0 | 245,000 | |
| Aug 16 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Payment of Exercise | F | 11.05 | 20,872 | 230,636 | 141,337 | 162.2 K to 141.3 K (-12.87 %) |
| Aug 16 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 0.00 | 40,000 | 0 | 162,209 | 122.2 K to 162.2 K (+32.73 %) |
| Jul 03 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 5.13 | 7,390 | 37,911 | 142,610 | |
| Jul 03 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 3.55 | 27,654 | 98,172 | 0 | |
| Jul 03 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 11.00 | 7,390 | 81,290 | 122,209 | 129.6 K to 122.2 K (-5.70 %) |
| Jul 03 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 5.13 | 7,390 | 37,911 | 129,599 | 122.2 K to 129.6 K (+6.05 %) |
| Jul 03 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 11.00 | 27,654 | 304,194 | 122,209 | 149.9 K to 122.2 K (-18.45 %) |
| Jul 03 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 3.55 | 27,654 | 98,172 | 149,863 | 122.2 K to 149.9 K (+22.63 %) |
| Jun 22 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 3.55 | 40,000 | 142,000 | 27,654 | |
| Jun 22 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 3.55 | 30,000 | 106,500 | 67,654 | |
| Jun 22 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 10.91 | 40,000 | 436,528 | 122,209 | 162.2 K to 122.2 K (-24.66 %) |
| Jun 22 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 3.55 | 40,000 | 142,000 | 162,209 | 122.2 K to 162.2 K (+32.73 %) |
| Jun 22 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 10.90 | 30,000 | 327,099 | 122,209 | 152.2 K to 122.2 K (-19.71 %) |
| Jun 22 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 3.55 | 30,000 | 106,500 | 152,209 | 122.2 K to 152.2 K (+24.55 %) |
| Jun 14 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 0.00 | 50,000 | 0 | 285,000 | |
| Jun 14 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 0.00 | 5,000 | 0 | 335,000 | |
| Jun 14 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Payment of Exercise | F | 10.75 | 26,090 | 280,468 | 122,209 | 148.3 K to 122.2 K (-17.59 %) |
| Jun 14 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 0.00 | 50,000 | 0 | 148,299 | 98.3 K to 148.3 K (+50.87 %) |
| Jun 14 2017 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 0.00 | 5,000 | 0 | 98,299 | 93.3 K to 98.3 K (+5.36 %) |
| Jun 14 2017 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Option Exercise | M | 0.00 | 25,000 | 0 | 157,000 | |
| Jun 14 2017 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Option Exercise | M | 0.00 | 3,000 | 0 | 182,000 | |
| Jun 14 2017 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Option Exercise | M | 0.00 | 12,500 | 0 | 185,000 | |
| Jun 14 2017 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Sell | S | 10.75 | 25,000 | 268,750 | 1,872 | 26.9 K to 1.9 K (-93.03 %) |
| Jun 14 2017 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Sell | S | 10.75 | 3,000 | 32,250 | 26,872 | 29.9 K to 26.9 K (-10.04 %) |
| Jun 14 2017 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Sell | S | 10.75 | 12,500 | 134,375 | 29,872 | 42.4 K to 29.9 K (-29.50 %) |
| Jun 14 2017 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Buy | M | 0.00 | 25,000 | 0 | 42,372 | 17.4 K to 42.4 K (+143.91 %) |
| Jun 14 2017 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Buy | M | 0.00 | 3,000 | 0 | 17,372 | 14.4 K to 17.4 K (+20.87 %) |
| Jun 14 2017 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Buy | M | 0.00 | 12,500 | 0 | 14,372 | 1.9 K to 14.4 K (+667.74 %) |
| Jun 14 2017 | SCLN | SCICLONE PHARMACEU ... | Low Raymond Anthony | VP, Finance & Contr ... | Option Exercise | M | 0.00 | 1,250 | 0 | 21,250 | |
| Jun 14 2017 | SCLN | SCICLONE PHARMACEU ... | Low Raymond Anthony | VP, Finance & Contr ... | Buy | M | 0.00 | 1,250 | 0 | 15,536 | 14.3 K to 15.5 K (+8.75 %) |
| Jun 14 2017 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Option Exercise | M | 0.00 | 1,000 | 0 | 18,000 | |
| Jun 14 2017 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Sell | S | 10.75 | 1,000 | 10,750 | 0 | 1,000 to 0 (-100.00 %) |
| Jun 14 2017 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Buy | M | 0.00 | 1,000 | 0 | 1,000 | 0 to 1,000 |